Patent 7615356 was granted and assigned to Vertex Pharmaceuticals on November, 2009 by the United States Patent and Trademark Office.
A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.